共 96 条
- [1] Hu JX(2021)Pancreatic cancer: A review of epidemiology, trend, and risk factors World J Gastroenterol 27 4298-4321
- [2] Zhao CF(2018)Therapeutic developments in pancreatic cancer: current and future perspectives Nat Rev Gastroenterol Hepatol 15 333-348
- [3] Chen WB(2020)Pancreatic cancer The Lancet 395 2008-2020
- [4] Neoptolemos JP(2015)Fibroblast activation protein-alpha-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma BMC Gastroenterol 15 109-216
- [5] Kleeff J(2019)Immunotherapy of pancreatic cancer Prog Mol Biol Transl Sci 164 189-4276
- [6] Michl P(2012)The pancreas cancer microenvironment Clin Cancer Res 18 4266-158
- [7] Mizrahi JD(2008)Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma Pancreas 37 154-463
- [8] Surana R(2017)Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma JCI Insight 8 454-1465
- [9] Valle JW(2014)Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy Proteomics Clin Appl 14 1459-175
- [10] Kawase T(2019)Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma PLoS ONE 16 155-4590